Analysis of the Safety and Effectiveness of Endoscopic Nasal Dacryocystorhinostomy in the Remedy of Chronic Dacryocystitis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2024 Jan 19

PMID 38241549

Authors

Mingzhe Li

Wenping Li

Qian Sha

Liuying Yu

Xuefei Wang

Affiliations

Soon will be listed here.

Abstract

To estimate the safety and effectiveness of endoscopic nasal dacryocystorhinostomy in the remedy of chronic dacryocystitis. The clinical data of 105 subjects with chronic dacryocystitis enrolled into our hospital were analyzed retrospectively. The subjects were distinguished into nasal endoscopic group (endoscopic dacryocystorhinostomy; i.e., 51 cases) according to their surgical methods and external-route group (external-route dacryocystorhinostomy; i.e., 54 cases). The therapeutic effect, lacrimal gland secretion function, tear film stability, degree of epiphora, lacrimal passage patency, complications, and recurrence rate were contrasted between the 2 groups. The nasal endoscopic group exhibited a higher effective remedy rate (98.04%) compared with the external-route group (83.33%). Three months postoperation, both groups showed improvements in lacrimal gland secretion function and tear film stability, with the nasal endoscopic group demonstrating more significant enhancement in lacrimal gland secretion function than the external-route group. Six months postoperation, a reduction in the degree of epiphora was observed in both groups, with the nasal endoscopic group displaying a more pronounced decrease in epiphora severity and a higher lacrimal passage patency rate than the external-route group. Furthermore, the nasal endoscopic group experienced lower incidences of postoperative complications and recurrence rates. Endoscopic dacryocystorhinostomy is safe and effective in the remedy of chronic dacryocystitis.

References

Rolfo C, Cardona A, Cristofanilli M, Paz-Ares L, Diaz Mochon J, Duran I . Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB). Crit Rev Oncol Hematol. 2020; 151:102978. DOI: 10.1016/j.critrevonc.2020.102978. View

Luchtenberg M, Tratz F, Schalnus R, Helbig M, May A . [Endonasal dacryocystorhinostomies with transillumination and intubation in patients with combined pathologies of the nose and after revision]. Klin Monbl Augenheilkd. 2012; 230(1):46-50. DOI: 10.1055/s-0032-1327955. View

Isaev E, Egorov V, Isaev V, Svistushkin V, Pustovit O . [Method of endonasal endoscopic dacryocystorhinostomy with plastic stoma formation]. Vestn Otorinolaringol. 2021; 86(1):58-62. DOI: 10.17116/otorino20218601158. View

Ali M . Pediatric dacryocystorhinostomy. Indian J Ophthalmol. 2017; 65(10):1008-1009. PMC: 5678298. DOI: 10.4103/ijo.IJO_696_17. View

Pradhan P, Samal S . Rhinosporidiosis of the lacrimal sac masquerading as chronic dacryocystitis: a rare presentation. Autops Case Rep. 2021; 11:e2020214. PMC: 8020589. DOI: 10.4322/acr.2020.214. View

Vinciguerra A, Resti A, Rampi A, Bussi M, Bandello F, Trimarchi M . Endoscopic and external dacryocystorhinostomy: A therapeutic proposal for distal acquired lacrimal obstructions. Eur J Ophthalmol. 2022; 33(3):1287-1293. PMC: 10152216. DOI: 10.1177/11206721221132746. View

Liu C, Fang C, Shang Y, Yao B, He Q . Transcranial ultrasound diagnostic value of hemodynamic cerebral changes in preterm infants for early-onset sepsis. Transl Pediatr. 2022; 11(7):1149-1155. PMC: 9360823. DOI: 10.21037/tp-22-269. View

Meireles M, Viveiros M, Meneghin R, Galindo-Ferreiro A, Marques M, Schellini S . Dacryocystectomy as a treatment of chronic dacryocystitis in the elderly. Orbit. 2017; 36(6):419-421. DOI: 10.1080/01676830.2017.1353111. View

Heichel J, Sandner A, Siebolts U, Bethmann D, Struck H . [Concretions and iatrogenic foreign bodies in the lacrimal system : Treatment recommendations]. HNO. 2016; 64(6):403-16. DOI: 10.1007/s00106-016-0170-6. View

10.

Saenz Gonzalez A, Busquet I Duran N, Arambulo O, Badal Alter J . Chronic dacryocystitis caused by sarcoidosis. Arch Soc Esp Oftalmol (Engl Ed). 2018; 94(4):188-191. DOI: 10.1016/j.oftal.2018.10.010. View

11.

Dogan M, Alizada A, Yavas G, Kahveci O, Bakan O . Laser-assisted dacryocystorhinostomy in nasolacrimal duct obstruction: 5-year follow-up. Int J Ophthalmol. 2018; 11(10):1616-1620. PMC: 6192962. DOI: 10.18240/ijo.2018.10.07. View

12.

Zhang L, Jin P, Li J, Zhu F . [Application of test-negative design in vaccine efficacy evaluation]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41(2):280-283. DOI: 10.3760/cma.j.issn.0254-6450.2020.02.024. View

13.

Habib M, Saunders P, Rubinstein T . Stenotrophomonas maltophilia-Associated Dacryocystitis in Leukemia-Infiltrated Lacrimal Sacs: Case and Review of Literature. Ophthalmic Plast Reconstr Surg. 2021; 37(4):e143-e145. DOI: 10.1097/IOP.0000000000001925. View

14.

Anand Chavadaki J, Raghu K, Patel V . A Retrospective Study of Establishment of Association Between Deviated Nasal Septum, Sinusitis and Chronic Dacryocystitis. Indian J Otolaryngol Head Neck Surg. 2020; 72(1):70-73. PMC: 7040112. DOI: 10.1007/s12070-019-01745-4. View

15.

Fayet B, Racy E, Katowitz J, Katowitz W . Endoscopic dacryocystorhinostomy, operculum of the middle turbinate and optimal clearance of the common canaliculus. J Fr Ophtalmol. 2020; 43(7):574-576. DOI: 10.1016/j.jfo.2020.02.002. View

16.

Baybora H, Uysal H, Baykal O, Karabela Y . Investigating Estrogen and Progesterone Receptors in the Lacrimal Sacs of Individuals With and Without Chronic Dacryocystitis. Beyoglu Eye J. 2022; 4(1):38-41. PMC: 8842039. DOI: 10.14744/bej.2019.35744. View

17.

Resti A, Vinciguerra A, Bordato A, Rampi A, Tanzini U, Mattalia L . The importance of clinical presentation on long-term outcomes of external dacryocystorhinostomies: Our experience on 245 cases. Eur J Ophthalmol. 2021; 32(5):2646-2651. DOI: 10.1177/11206721211059702. View

18.

Vidas Pauk S, Petricek I, Tomic M, Bulum T, Jandrokovic S, Kalauz M . Manual interferometric device for routine non-invasive tear film break-up time assessment. Semin Ophthalmol. 2021; 36(3):94-102. DOI: 10.1080/08820538.2021.1884272. View

19.

Turkoglu G, Berkem R, Karakoc A . [Investigation of the diagnostic value of anti-dense fine speckled 70/lens epithelium derived growth factor p75 autoantibody for autoimmune diseases]. Mikrobiyol Bul. 2018; 52(4):413-424. DOI: 10.5578/mb.67385. View

20.

Zabek O, Eggenschwiler L, Goldblum D, Meyer P . Filamentous Fungus Dacryolith as a Cause of Chronic Dacryocystitis. Klin Monbl Augenheilkd. 2021; 238(4):356-357. DOI: 10.1055/a-1356-5331. View